EyeEm grabs $18 mln

Berlin-based mobile photography marketplace EyeEm has secured $18 million in funding, according to a blog post on its site. Valar Ventures led the round with participation from previous backers Earlybird Ventures, Passion Capital, Wellington Partners, Atlantic Labs and Open Ocean Capital. To read the announcement, visit here.

 

Wellington Partners backs Onfido

London-based Onfido, which specializes in providing background checks for companies, has secured $4.5 million in Series A funding, the company announced in a blog post on its site. Wellington Partners led the round with other investors that included CrunchFund. According to Onfido, the capital infusion will be used for personnel hiring and technology development. To read the announcement, visit here.

 

102 Views

Cavendish Kinetics picks up $7 mln

Cavendish Kinetics has received $7 million in funding. Tallwood Venture Capital and Wellington Partners led the round with participation from other investors that included Qualcomm Ventures. In addition to the funding, the firm has added Gilles Delfassy to its board of directors. Cavendish Kinetics is a provider of high-performance RF MEMS tuning solutions for mobile and wearable devices.

139 Views

ALIAD leads 27 mln pounds funding in Quanta Fluid Solutions

Quanta Fluid Solutions, a UK-based provider of advanced haemodialysis systems, has raised about 27 million pounds in funding. ALIAD led the round with participation from Seventure Partners, Wellington Partners, Seroba Kernel, NBGI Ventures, b-to-v Partners and IMI plc.

Rigontec raises $11.95 mln

Rigontec GmbH said Tuesday it raised €9.45 million (US$11.95 million) in a first close of a Series A round co-led by Wellington Partners and Boehringer Ingelheim Venture Fund. Other investors include NRW Bank and High-Tech Gründerfonds. Rigontec, a biopharmaceutical company, is developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases.

110 Views

Heliatek completes Series C

Heliatek has completed a series C financing. The round was led by AQTON SE with participation from existing investors Bosch, BASF, Innogy Venture Capital, Wellington Partners, eCAPITAL, HTGF and TGFS.

Neuway Pharma appoints advisory board member

Biotech start-up company NEUWAY Pharma has appointed Dr. Wolfgang Baiker as a new Member of its advisory board. NEUWAY Pharma GmbH was founded in April 2014 as the first spin-off from Life Science Inkubator, Bonn, and secured series A financing from a syndicate led by Wellington Partners.

Nosto Solutions picks up $5.5 mln

Finnish e-commerce software firm Nosto Solutions said Tuesday that it has closed $5.5 million in funding. Wellington Partners led the round with participation from Open Ocean Capital, SanomaVentures and Tekes, the Finnish Funding Agency for Innovation.

Definiens gets further backing

Wellington Partners and Gilde Healthcare have co-led an investment round in Munich, Germany-based Definiens. Existing investors Cipio Partners and TVM Capital also participated.

172 Views

Wellington Partners leads NEUWAY Series A

Wellington Partners has led a series A financing round at German-based NEUWAY Pharma GmbH. The business is the first spin-off from Life Science Inkubator in Bonn. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases.

113 Views

Gamma Capital, Texas Atlantic and Wellington Partners back Opvizor

Opvizor has received an undisclosed amount of funding. The investors were Gamma Capital Partners, Texas Atlantic Capital and Wellington Partners. In conjunction with the funding, Moshe Bar, general partner of Texas Atlantic Capital, has been named to Opvizor’s board of directors. Based in Houston, Opvizor is a provider of predictive analysis and issue prevention in virtual datacenter environments.

Invendo Medical scores $28 mln

Invendo Medical said Thursday that it has raised $28 million in financing. Xeraya Capital led the round with participation from other investors that included TVM Capital, Wellington Partners and 360° Capital. Based in New York and Kissing, Germany, Invendo Medical is a colonoscopy system maker.

Glo AB completes $30 mln Series D

Glo has completed a $30 million Series D financing. Glo provides high-quality light source solutions for displays, illumination, and automotive sectors. A new investor led the round, with participation from existing shareholders including Wellington Partners, Teknoinvest, Nano Future Invest, Energy Future Invest, Foundation Asset Management and others.

Daniel Waterhouse joins Balderton Capital

Balderton Capital has appointed Daniel Waterhouse, formerly at Wellington Partners, as a general partner. Waterhouse will be based in London and will help lead early stage investments in the software and internet sectors.

immatics biotechnologies closes Series D

immatics biotechnologies has closed a Series D financing round. The funding round was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, MIG-advised funds and AT Impf GmbH. immatics biotechnologies is a clinical-stage biopharmaceutical company developing advanced multi-peptide cancer vaccines that are active against cancer.

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget